Working… Menu

Nivolumab With Chemotherapy in Refractory MDS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03259516
Recruitment Status : Terminated (Slow recruitment rate)
First Posted : August 23, 2017
Last Update Posted : April 5, 2019
Information provided by (Responsible Party):
Ivan S Moiseev, St. Petersburg State Pavlov Medical University

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 25, 2018
Actual Study Completion Date : December 25, 2018